Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Kronisk bihulebetændelse og type 2-sygdom

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Basal og avanceret behandling af børn og voksne med epilepsi

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Behandling af status epilepticus hos børn og voksne

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Depression og angst hos voksne patienter med epilepsi

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Genetikken fremmer individualiseret behandling af epilepsi

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Kognitive vanskeligheder ved epilepsi

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Diseases of the upper and lower airways are commonly described as global airway disease, which shares basic inflammatory mechanisms, and airway comobidity is frequently found. The prevalence of chronic rhinosinusitis (CRS) is 5-12%, characterised as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). Inflammation in CRSwNP is often type 2, whereas CRSsNP often involves non-type 2. New monoclonal antibodies towards type-2 inflammation have been launched internationally to treat refractory severe CRSwNP, with effect on polyps, congestions and smell, as well as quality of life. This review gives a summary of the current treatment modalities.

Bidragets oversatte titelChronic rhinosinusitisand type 2 disease
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind184
Udgave nummer10
ISSN0041-5782
StatusUdgivet - 7 mar. 2022

    Forskningsområder

  • Chronic Disease, Humans, Nasal Polyps/complications, Quality of Life, Rhinitis/complications, Sinusitis/complications

ID: 76237167